Search

Your search keyword '"drug effects [Brain]"' showing total 60 results

Search Constraints

Start Over You searched for: Descriptor "drug effects [Brain]" Remove constraint Descriptor: "drug effects [Brain]"
60 results on '"drug effects [Brain]"'

Search Results

1. Inhibition of formyl peptide receptors improves the outcome in a mouse model of Alzheimer disease

2. Lack of association between proton pump inhibitor use and brain aging: a cross-sectional study

Catalog

Books, media, physical & digital resources

3. Emerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer's Disease

4. Oxytocin reduces a chemosensory-induced stress bias in social perception

5. BACE1 inhibition more effectively suppresses initiation than progression of β-amyloid pathology

6. Evidence for Stress-like Alterations in the HPA-Axis in Women Taking Oral Contraceptives

7. Preserved structural connectivity mediates the clinical effect of thrombolysis in patients with anterior-circulation stroke

8. Enduring Changes in Neuronal Function upon Systemic Inflammation Are NLRP3 Inflammasome Dependent

9. Human gestational N-methyl-d-aspartate receptor autoantibodies impair neonatal murine brain function

10. Effects of spermidine supplementation on cognition and biomarkers in older adults with subjective cognitive decline (SmartAge)—study protocol for a randomized controlled trial

11. Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial): Rationale and study design

12. Sirtuin 2 Inhibition Improves Cognitive Performance and Acts on Amyloid-β Protein Precursor Processing in Two Alzheimer’s Disease Mouse Models

13. Disease-modifying strategies in primary tauopathies

14. Oral and intravenous transmission of α-synuclein fibrils to mice

15. Single-Cell Transcriptomics Analyses of Neural Stem Cell Heterogeneity and Contextual Plasticity in a Zebrafish Brain Model of Amyloid Toxicity

16. Hormonal contraceptives suppress oxytocin-induced brain reward responses to the partner’s face

17. Interplay of pathogenic forms of human tau with different autophagic pathways

18. Modeling Amyloid-β42 Toxicity and Neurodegeneration in Adult Zebrafish Brain

19. Brain diffusion tensor imaging changes in cerebrotendinous xanthomatosis reversed with treatment

20. How the brain codes intimacy: The neurobiological substrates of romantic touch

21. Childhood adversity impacts on brain subcortical structures relevant to depression

22. An Oxytocin-Induced Facilitation of Neural and Emotional Responses to Social Touch Correlates Inversely with Autism Traits

23. Annonacin, a natural lipophilic mitochondrial complex I inhibitor, increases phosphorylation of tau in the brain of FTDP-17 transgenic mice

24. Persistence of Aβ seeds in APP null mouse brain

25. Dysregulation of Neurotrophic and Haematopoietic Growth Factors in Alzheimer’s Disease: From Pathophysiology to Novel Treatment Strategies

26. Reduced Alzheimer’s Disease Pathology by St. John’s Wort Treatment is Independent of Hyperforin and Facilitated by ABCC1 and Microglia Activation in Mice

27. Dopamine restores reward prediction errors in old age

28. Enhanced motivation to alcohol in transgenic mice expressing human α-synuclein

29. Chronic consumption of Annona muricata juice triggers and aggravates cerebral tau phosphorylation in wild-type and MAPT transgenic mice

30. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease

31. PPARγ/RXRα-Induced and CD36-Mediated Microglial Amyloid-β Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice

32. MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function

33. Biodistribution and brain permeability of the extracellular domain of neuregulin-1-β1

34. Functional connectivity increase in the default-mode network of patients with Alzheimer's disease after long-term treatment with Galantamine

35. Effects of rivastigmine on visual attention in subjects with amnestic mild cognitive impairment: A serial functional MRI activation pilot-study

36. Towards a pathway inventory of the human brain for modeling disease mechanisms underlying neurodegeneration

37. Oxytocin enhances cognitive control of food craving in women

38. Quantitative Real-Time Quaking-Induced Conversion Allows Monitoring of Disease-Modifying Therapy in the Urine of Prion-Infected Mice

39. Vascular change and opposing effects of the angiotensin type 2 receptor in a mouse model of vascular cognitive impairment

40. Efficient Cargo Delivery into Adult Brain Tissue Using Short Cell-Penetrating Peptides

41. Pharmacological inhibition of BACE1 impairs synaptic plasticity and cognitive functions

42. Glucocerebrosidase deficiency and mitochondrial impairment in experimental Parkinson disease

43. Oxytocin facilitates the sensation of social stress

44. N-acetyl-aspartate (NAA) as a correlate of pharmacological treatment in psychiatric disorders: a systematic review

45. The subthalamic nucleus modulates the early phase of probabilistic classification learning

46. Global and focal white matter integrity in breast cancer survivors 20 years after adjuvant chemotherapy

47. Aβ seeds resist inactivation by formaldehyde

48. Targeting histone-modifications in Alzheimer's disease. What is the evidence that this is a promising therapeutic avenue?

49. Fast Micro-iontophoresis of Glutamate and GABA: A Useful Tool to Investigate Synaptic Integration

50. Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease